Veranova

Devens, MA (US HQ); multiple global sites
Small Molecule API HPAPI ADC payload/linker Oligonucleotide Peptide
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (9) ○ EMA GMP ○ MHRA GMP

Quick Facts: Veranova

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Devens, MA (US HQ); multiple global sites
Modalities
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Veranova

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (5 modalities)

Recent News 9 articles

news Wed, 30 Ap
Lucas Sauer-Jones Appointed as Vice President & General Manager of Veranova’s New England Sites - CHEManager
Source →
news Wed, 18 Oc
Veranova’s shift to Dynamics 365 is good medicine - Microsoft
Source →
news Tue, 24 Ju
Veranova invests $50m in Massachusetts ADC manufacturing expansion - BioProcess International
Source →
news Tue, 02 Ap
Veranova Names Scott Lassonde as SVP and CFO - Contract Pharma
Source →
news Mon, 16 Ju
Veranova, Enzene plot new biologic manufacturing expansions on East Coast - Fierce Pharma
Source →
news Mon, 02 Se
Expert Statement: Rohtash Kumar, Veranova - CHEManager
Source →
news Mon, 01 Ju
API maker Veranova earmarks $30M to expand Massachusetts facility - Fierce Pharma
Source →
news Fri, 28 Ju
CDMO Veranova Announces Significant Investment For ADC And Highly Potent API Capabilities At Massachusetts Facility - Pharmaceutical Online
Source →
news Fri, 20 Ju
Enzene, Veranova separately unveil expansions; Lotte’s new ADC client - Endpoints News
Source →

Frequently Asked Questions About Veranova

What is Veranova's CDMO Signal Score?
Veranova has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Veranova for a manufacturing program?
Use the free AI matchmaker to compare Veranova against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
HPAPI CDMOs → ADC payload/linker CDMOs → Oligonucleotide CDMOs →

Similar CDMOs

Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products
Nitto Denko Avecia
Milford, MA
Signal Score: 80.3
Oligonucleotide, mRNA
ChemGenes Corporation
Wilmington, MA
Signal Score: 56.5
Oligonucleotide
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Bachem
Bubendorf, CH
Signal Score: 83.5
Oligonucleotide